Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
No reliable scientific data is available for "Uroplakin-3b-like protein 2" (UPK3BL2) in the published literature or referenced canonical protein/gene databases as of September 2025. Unlike the established uroplakin family members such as Uroplakin-3b (UPK3B), UPK3BL2 does not have recognized molecular function, classification, or disease associations in leading protein resources. UPK3BL2 is listed as a gene or protein entry in some bioinformatics resources, but there is no supporting evidence of it being a functionally characterized protein, therapeutic target, receptor, or clinically relevant biomarker in humans[4][5][6]. The available research focuses on known uroplakins (such as UPK3B, UPK3A, UPK1A, UPK1B, UPK2), which are structural proteins in the urothelial plaque and play roles in bladder epithelial integrity[1][2][3]. In summary, "UPK3BL2" appears to be either a computational prediction, an uncharacterized locus, or an alias with no current evidence of relevance as a molecular target. **Note:** - "Uroplakin-3b-like protein 2" (UPK3BL2) should not be confused with "Uroplakin 3b" (UPK3B), which is a well-characterized structural protein in the uroplakin family[1]. If you intended one of the canonical uroplakin targets, such as UPK3B, please clarify your query. - There is no data on structure, function, therapeutic relevance, druggability, or clinical applications for UPK3BL2 in any major scientific repository as of the current search.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Uroplakin-3b-like protein 2 (UPK3BL2).